A follow‐up study with a double‐blinded, randomized controlled vitamin D supplementation trial in patients with major depressive episode ( DepFuD ): A study protocol and baseline characteristics
Food Science & Nutrition · 2024-10 · 12 (10) · 8454-8469
DOI: 10.1002/fsn3.4417 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift Food Science & Nutrition, online erschienen am 20.08.2024. Verfasst von T Mikola und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Medicine University of Eastern Finland Kuopio Finland. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Promising initial studies on vitamin D (VD) supplementation as an adjunct treatment for major depressive disorder (MDD) require rigorously designed randomized controlled trials (RCTs). We aim to investigate the effects of augmenting standard MDD treatment with VD supplementation and examine factors influencing the treatment outcome. This article describes the study design, measures, and baseline characteristics. This multicenter RCT compares the efficacy of a six‐month VD intervention at 100 micrograms/day versus 10 micrograms/day (μg/day) (4000 IU (international units)/day vs. 400 IU/day) added to a standard treatment in outpatients aged 20–61 years with MDD. The primary outcome is change in the Montgomery–Åsberg Depression Rating Scale (MADRS) score. Secondary outcomes are other indicators of mental health and functionality (BDI, SOC, 15‐D, PSS10, LS‐4, LOT‐R, YSQ‐S2‐extended, CORE‐OM, TAS‐20, BRCS, TADS, SCL‐90, DIAD, GAF), and circulating biomarkers. Intervention assessments are conducted at baseline, 3, and 6 months, and follow‐ups at 18 months and 6 years post‐baseline. The baseline sample had 319 subjects (74% women; median age 31 (inter‐quartile range (IQR) 15), mean MADRS score 21.38 (SD 6.04)), with 281 assigned to the RCT. At present, the study continues as a follow‐up study. DepFuD project will provide extensive information regarding the potential benefits of VD and enables to identify various biopsychosocial depression‐associated risk factors.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Clinical Medicine University of Eastern Finland Kuopio Finland.
- Institute of Clinical Medicine University of Oslo Oslo Norway.
- R&D Department, Division of Mental Health Services Akershus University Hospital Lørenskog Norway.
- Department of Psychiatry University of Helsinki Helsinki Finland.
- School of Educational Sciences and Psychology, Philosophical Faculty University of Eastern Finland Joensuu Finland.
- Mental Health and Wellbeing, Kuopio University Hospital Wellbeing Services County of North Savo Kuopio Finland.
ORCID-Profile: T Mikola
Zitieren
APA
Mikola, T., Lehto, S. M., Honkalampi, K., Valkonen-Korhonen, M., Koivumaa-Honkanen, H., Tolmunen, T., Laukkanen, V., Pakarinen, M., & Ruusunen, A. (2024). A follow‐up study with a double‐blinded, randomized controlled vitamin D supplementation trial in patients with major depressive episode ( DepFuD ): A study protocol and baseline characteristics. Food Science & Nutrition, 12(10), 8454-8469. https://doi.org/10.1002/fsn3.4417
Vancouver
Mikola T, Lehto SM, Honkalampi K, Valkonen-Korhonen M, Koivumaa-Honkanen H, Tolmunen T, et al. A follow‐up study with a double‐blinded, randomized controlled vitamin D supplementation trial in patients with major depressive episode ( DepFuD ): A study protocol and baseline characteristics. Food Science & Nutrition. 2024;12(10):8454-8469. doi:10.1002/fsn3.4417
BibTeX
@article{Mikola2024,
author = {Mikola, T and Lehto, S M and Honkalampi, K and Valkonen-Korhonen, M and Koivumaa-Honkanen, H and Tolmunen, T and Laukkanen, V and Pakarinen, M and Ruusunen, A},
title = {A follow‐up study with a double‐blinded, randomized controlled vitamin D supplementation trial in patients with major depressive episode ( DepFuD ): A study protocol and baseline characteristics},
journal = {Food Science & Nutrition},
year = {2024},
volume = {12},
number = {10},
pages = {8454--8469},
doi = {10.1002/fsn3.4417}
}
EUVIMED